CClinicalTrials.gg
CompletedNCT00677690Updated Nov 16, 2011Results posted

Neuromuscular Electrical Stimulation in Chronic Obstructive Pulmonary Disease (COPD)

A Phase 3 interventional study of neuromuscular electrical stimulation (NMES) and Sham electrical stimulation in Chronic Obstructive Pulmonary Disease, sponsored by Fondazione Salvatore Maugeri. Completed at 1 site in Italy. Open to participants aged 60 Years to 80 Years. Per ClinicalTrials.gov, last updated 2011-11-16.

Sponsored by Fondazione Salvatore Maugeri · Phase 3, Interventional, and Treatment

Phase
Phase 3
Study type
Interventional
Enrollment
83
Allocation
Randomized
Ages
60 Years to 80 Years
Sex
All
01

Study summary

The purpose of this study is to elucidate whether combination of usual pulmonary rehabilitation and neuromuscular electrical stimulation of quadriceps may improve exercise capacity in patients affected by chronic obstructive pulmonary disease (COPD).

Read the detailed description

Neuromuscular electrical stimulation (NMES) has been extensively used as technique to improve muscle function in different areas of rehabilitation, however it seems to be more appropriate in critical care situation, while its use in more able patients is of uncertain benefit. In other words, NMES seems to be particularly effective in severely deconditioned and bed ridden patients. We therefore carried out a randomised trial to compare the efficacy of combination of NMES and PR (NM+PR) with combination of sham stimulation and PR (SS+PR) in a large population of moderately impaired COPD patients. Primary outcome was evaluation of effect of NMES on quadriceps strength and on exercise capacity. Secondary outcome was evaluation of effect of NMES on symptoms (dyspnoea) and quality of life.

02

Conditions studied

  • Chronic Obstructive Pulmonary Disease

Keywords

  • COPD
03

In context

Lung Diseases

3,303 studies on the registry are indexed under Lung Diseases; 355 are open to participants now.

This study's enrollment of 83 is above the median of 72 across 2,118 interventional studies indexed under Lung Diseases.

Browse Lung Diseases studies →

Lead sponsor

Fondazione Salvatore Maugeri is the lead sponsor of 23 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Clinical diagnosis of COPD
  • Must be able to walk

Exclusion criteria

Exclusion Criteria:

  • Previous or current diagnosis of chronic respiratory failure
  • A history of diseases other than COPD, in particular neurological disease
  • Need for treatment with systemic steroids during the rehabilitation period
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
83 participants (actual)

Study arms

  • Active comparator
    NM+PR

    Patients undergone to combination of neuromuscular stimulation and pulmonary rehabilitation (NM+PR)

    Other: neuromuscular electrical stimulation (NMES)

  • Placebo comparator
    SS+PR

    Patients undergone to pulmonary rehabilitation

    Other: Sham electrical stimulation

Interventions

  • Otherneuromuscular electrical stimulation (NMES)

    NMES was applied by means of a commercially available four channel electrostimulator which generated a symmetrical biphasic pulsed current. Each session lasted 30 minutes and was performed 5 days/week for 5 weeks.

    Also known as: pulmonary rehabilitation

  • OtherSham electrical stimulation

    Sham stimulation was performed with the same modality and time, but the stimulus was set up at 5 Hz.

    Also known as: pulmonary rehabilitation

06

What researchers measure

Primary outcomes

  1. Exercise Capacity

    6 minute walk test(6MWT)

    Time frame: 5 weeks

  2. Quadriceps Strength

    Quadriceps strength was assessed by means of Sit to Stand Test (STST). The subjects held their arms stationary by putting their hands on their hips. The subjects were asked to complete the sitting and standing positions without using the arms for support while rising and sitting. Once instructed, subjects stand upright and without delay sit down again, repeating the procedure as many times as possible in a 1 min period. The number of completed repetitions was recorded. The subjects were permitted to use rest periods to complete 1 min.

    Time frame: 5 weeks

Secondary outcomes

  1. Dyspnoea

    The modified Medical Research Council (MMRC) scale was used for rating dyspnoea. MMRC is a five-point scale based on degrees of various physical activities that precipitate breathlessness. Scores on the MMRC dyspnoea scale can range from 0 (normal) to 4.

    Time frame: 5 weeks

  2. Quality of Life

    St. George's respiratory questionnaire is a standardized self-administered airways disease-specific questionnaire divided into three subscales: symptoms (eight items), activity (16 items), and impacts (26 items). For each subscale and for the overall questionnaire, scores range from zero (no impairment) to 100 (maximum impairment).

    Time frame: 5 weeks

  3. Respiratory Function

    forced expiratory volume in 1 second (FEV1)

    Time frame: 5 weeks

07

Results

Posted Apr 20, 2009

Participant flow

2007-2008 - Rehabilitative Pulmonary ward

Participant flow — Overall Study
MilestoneNeuromuscular Stimulation and Pulmonary RehabilitationPulmonary Rehabilitation
Started4241
Completed4241
Not completed00

Outcome measures

SecondaryDyspnoea

The modified Medical Research Council (MMRC) scale was used for rating dyspnoea. MMRC is a five-point scale based on degrees of various physical activities that precipitate breathlessness. Scores on the MMRC dyspnoea scale can range from 0 (normal) to 4.

Time frame:
5 weeks
Reported as:
Mean · units on a scale
Dyspnoea
units on a scaleNeuromuscular Stimulation and Pulmonary RehabilitationPulmonary Rehabilitation
Dyspnoea2.4 ± 0.42.6 ± 0.2
Statistical analysis
  • Neuromuscular Stimulation and Pulmonary Rehabilitation vs Pulmonary Rehabilitation · t-test, 1 sided · p = < 0.05
PrimaryExercise Capacity

6 minute walk test(6MWT)

Time frame:
5 weeks
Reported as:
Mean · meters
Exercise Capacity
metersNeuromuscular Stimulation and Pulmonary RehabilitationPulmonary Rehabilitation
Exercise Capacity465.5 ± 101.7462.7 ± 96.9
Statistical analysis
  • Neuromuscular Stimulation and Pulmonary Rehabilitation vs Pulmonary Rehabilitation · t-test, 1 sided · p = <0.05
SecondaryQuality of Life

St. George's respiratory questionnaire is a standardized self-administered airways disease-specific questionnaire divided into three subscales: symptoms (eight items), activity (16 items), and impacts (26 items). For each subscale and for the overall questionnaire, scores range from zero (no impairment) to 100 (maximum impairment).

Time frame:
5 weeks
Reported as:
Mean · units on a scale
Quality of Life
units on a scaleNeuromuscular Stimulation and Pulmonary RehabilitationPulmonary Rehabilitation
Quality of Life41.7 ± 14.842.05 ± 15.7
Statistical analysis
  • Neuromuscular Stimulation and Pulmonary Rehabilitation vs Pulmonary Rehabilitation · t-test, 1 sided · p = <0.05
PrimaryQuadriceps Strength

Quadriceps strength was assessed by means of Sit to Stand Test (STST). The subjects held their arms stationary by putting their hands on their hips. The subjects were asked to complete the sitting and standing positions without using the arms for support while rising and sitting. Once instructed, subjects stand upright and without delay sit down again, repeating the procedure as many times as possible in a 1 min period. The number of completed repetitions was recorded. The subjects were permitted to use rest periods to complete 1 min.

Time frame:
5 weeks
Reported as:
Mean · repetitions
Quadriceps Strength
repetitionsNeuromuscular Stimulation and Pulmonary RehabilitationPulmonary Rehabilitation
Quadriceps Strength13.5 ± 0.8313.6 ± 0.99
Statistical analysis
  • Neuromuscular Stimulation and Pulmonary Rehabilitation vs Pulmonary Rehabilitation · t-test, 1 sided · p = <0.05
SecondaryRespiratory Function

forced expiratory volume in 1 second (FEV1)

Time frame:
5 weeks
Reported as:
Mean · percentage of predicted value
Respiratory Function
percentage of predicted valueNeuromuscular Stimulation and Pulmonary RehabilitationPulmonary Rehabilitation
Respiratory Function50.1 ± 6.449.6 ± 8.2
Statistical analysis
  • Neuromuscular Stimulation and Pulmonary Rehabilitation vs Pulmonary Rehabilitation · t-test, 1 sided · p = <0.05

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Neuromuscular Stimulation and Pulmonary Rehabilitation———
Pulmonary Rehabilitation———

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Neuromuscular Stimulation and Pulmonary RehabilitationPulmonary RehabilitationTotal
<=18 years000
Between 18 and 65 years11920
>=65 years313263
Age Continuous
Age Continuous(years)Neuromuscular Stimulation and Pulmonary RehabilitationPulmonary RehabilitationTotal
Mean61.4 ± 7.662.8 ± 5.462.1 ± 8.4
Sex: Female, Male
Sex: Female, Male(Participants)Neuromuscular Stimulation and Pulmonary RehabilitationPulmonary RehabilitationTotal
Female111223
Male312960
Region of Enrollment
Region of Enrollment(participants)Neuromuscular Stimulation and Pulmonary RehabilitationPulmonary RehabilitationTotal
Italy424183
08

Study locations

1 site
  • Fondazione Salvatore Maugeri
    Montescano, Pavia 27040, Italy
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 16, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00677690
Lead sponsor
Fondazione Salvatore Maugeri
Responsible party
Ercole Zanotti (MD, Fondazione Salvatore Maugeri) — Principal investigator
First posted
May 14, 2008
Start date
Jan 2007
Primary completion
Mar 2008
Completion
Jan 2009
Results posted
Apr 20, 2009
Last update
Nov 16, 2011

Study contacts

ercole zanotti, MD
principal investigator · Fondazione Maugeri

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion